|

ARO-MAPT-SC Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Arrowhead Pharmaceuticals1

Indications

  • Alzheimer's Disease1
  • Alzheimer Disease, Early Onset1
  • Alzheimer Disease1

Other1 trial

Study of ARO-MAPT-SC in Healthy Subjects and Subjects With Early Alzheimer's Disease
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.